Healthcare provider profile · identity verified

Rodrigo David Cantu, M.D.

Family Practice · SAN ANTONIO, TX · NPI 1659340982

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	462	129
Atorvastatin Calcium	Atorvastatin Calcium	449	123
Rosuvastatin Calcium	Rosuvastatin Calcium	381	115
Lisinopril	Lisinopril	265	80
Amlodipine Besylate	Amlodipine Besylate	259	81
Losartan Potassium	Losartan Potassium	251	71
Metformin Hcl	Metformin Hcl	235	70
Pantoprazole Sodium	Pantoprazole Sodium	211	75
Gabapentin	Gabapentin	204	55
Metoprolol Succinate	Metoprolol Succinate	194	53
Simvastatin	Simvastatin	180	55
Omeprazole	Omeprazole	175	51
Tamsulosin Hcl	Tamsulosin Hcl	171	50
Albuterol Sulfate Hfa	Albuterol Sulfate	168	73
Alprazolam	Alprazolam	167	35
Trazodone Hcl	Trazodone Hcl	163	51
Metformin Hcl Er	Metformin Hcl	156	42
Escitalopram Oxalate	Escitalopram Oxalate	142	42
Meloxicam	Meloxicam	134	53
Carvedilol	Carvedilol	131	39
Tramadol Hcl	Tramadol Hcl	130	33
Montelukast Sodium	Montelukast Sodium	120	34
Pravastatin Sodium	Pravastatin Sodium	115	31
Hydrochlorothiazide	Hydrochlorothiazide	111	38
Tizanidine Hcl	Tizanidine Hcl	109	36
Olmesartan Medoxomil	Olmesartan Medoxomil	103	32
Ozempic	Semaglutide	96	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	93	25
Sertraline Hcl	Sertraline Hcl	82	24
Furosemide	Furosemide	79	31
Allopurinol	Allopurinol	77	27
Pregabalin	Pregabalin	77	15
Fluticasone Propionate	Fluticasone Propionate	75	32
Duloxetine Hcl	Duloxetine Hcl	68	19
Januvia	Sitagliptin Phosphate	63	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	suppressed
Potassium Chloride	Potassium Chloride	62	20
Spironolactone	Spironolactone	61	15
Donepezil Hcl	Donepezil Hcl	58	15
Clonazepam	Clonazepam	57	11
Finasteride	Finasteride	57	20
Jardiance	Empagliflozin	54	18
Famotidine	Famotidine	53	18
Fluoxetine Hcl	Fluoxetine Hcl	53	16
Prednisone	Prednisone	53	37
Acetaminophen-Codeine	Acetaminophen With Codeine	49	12
Alendronate Sodium	Alendronate Sodium	49	13
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	48	14
Clopidogrel	Clopidogrel Bisulfate	47	16
Glipizide Er	Glipizide	45	13
Zolpidem Tartrate	Zolpidem Tartrate	45	suppressed
Bupropion Xl	Bupropion Hcl	41	11
Methocarbamol	Methocarbamol	41	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	13
Metoprolol Tartrate	Metoprolol Tartrate	39	12
Xarelto	Rivaroxaban	39	suppressed
Azithromycin	Azithromycin	37	34
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Trulicity	Dulaglutide	37	suppressed
Farxiga	Dapagliflozin Propanediol	35	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Estradiol	Estradiol	33	13
Repatha Sureclick	Evolocumab	33	suppressed
Tresiba Flextouch U-100	Insulin Degludec	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	32	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Celecoxib	Celecoxib	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Valsartan	Valsartan	29	suppressed
Eliquis	Apixaban	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	28	suppressed
Lactulose	Lactulose	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Glipizide	Glipizide	26	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Atenolol	Atenolol	24	suppressed
Azelastine Hcl	Azelastine Hcl	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	19
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	23	suppressed
Temazepam	Temazepam	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	16
Ondansetron Odt	Ondansetron	22	11
Ramipril	Ramipril	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Cephalexin	Cephalexin	21	20
Nebivolol Hcl	Nebivolol Hcl	21	suppressed
Amoxicillin	Amoxicillin	20	17
Chlorthalidone	Chlorthalidone	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Progesterone	Progesterone, Micronized	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Vascepa	Icosapent Ethyl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Fenofibrate	Fenofibrate	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Glimepiride	Glimepiride	15	suppressed
Levofloxacin	Levofloxacin	15	14
Methylprednisolone	Methylprednisolone	15	14
Promethazine Hcl	Promethazine Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Tramadol Hcl Er	Tramadol Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Torsemide	Torsemide	14	suppressed
Baclofen	Baclofen	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Fluconazole	Fluconazole	13	11
Irbesartan	Irbesartan	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Topiramate	Topiramate	12	suppressed
Dexilant	Dexlansoprazole	11	suppressed
Lexapro	Escitalopram Oxalate	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error